Answers are grounded in this paper and cite their sources.
The perspectives of patients with geographic atrophy (GA) should be considered when planning new clinical trials to ensure that real-world patient needs are addressed. The purpose of this study was to explore the perspectives of patients, caregivers, and trial site staff on designing and planning a phase 2 clinical trial in GA. This cross-sectional study included patients with GA and their caregivers, trial site staff, and investigators from Germany, the UK, and the USA. Participants were asked to spend 30 min reviewing a simulated trial design communicated as a simple video animation with a voiceover. Subsequently, a 90-min web-assisted telephone interview and survey was conducted to identify problems with the design of the simulated trial and explore potential solutions and improvements. Patients (n = 11), caregivers (n = 11), and site staff (n = 16) completed the survey after reviewing the simulated trial design. Survey responses suggested that study recruitment could be facilitated via widespread advertisement and by including a short washout period, i.e., the time period during which patients receive no medication prior to commencing the study drug to ensure that other treatments do not impact the study results. Survey suggestions for reducing the burden of trial participation included minimizing the number and frequency of trial visits, enabling assessments to be completed at home, and making the schedule of trial visits flexible. Appropriate investment in study center facilities was recommended. In addition, survey respondents proposed that providing transport could be highly beneficial, potentially enabling patients and caregivers to attend trial visits more easily. This study provides valuable information on the viewpoints of patients, caregivers, and trial site staff regarding trial design. Accounting for these perspectives when designing future clinical trials may help ensure successful trial completion and promote positive perceptions of clinical research. Geographic atrophy (GA) is an advanced form of age-related macular degeneration and is a major cause of vision loss. GA affects many aspects of everyday life, including carrying out daily tasks, recognizing faces, and driving. Given the limitations experienced by people with GA, when planning clinical trials, patients’ points of view should be considered. This trial simulation study explored the views of patients, caregivers, and trial site staff from Germany, the UK, and the USA on designing and planning a phase 2 clinical trial in GA. Participants provided potential improvements to the clinical trial design and solutions to recruitment challenges, including widespread advertisement and reducing patients’ time off their existing treatment before starting the study drug. Reducing the number of times and how often patients would need to go to the clinic, allowing patients to schedule these visits at convenient times, or enabling assessments to be completed at home would also make it easier for patients to participate in the study. Providing transport to the clinic for trial visits could help some patients to attend without their caregivers. Considering these factors when designing future clinical trials may enable more patients to participate in and complete trials and may promote a positive view of clinical research.
No takes yet. Share an insight, caveat, or question.
Gunderson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: